Summary
The influence of food intake (standardized breakfast) on the oral single-dose kinetics and effects of tolbutamide (0.5 g) and chlorpropamide (250 mg) was investigated in young, healthy volunteers. The single-dose kinetics of the two drugs was also studied in elderly healthy subjects. There was great interindividual variation in the elimination rate of both drugs, but food intake influenced neither their AUCs nor their rates of absorption and elimination. The peak concentration of chlorpropamide, but not that of tolbutamide, was reduced by food intake. The peak concentrations of serum tolbutamide were approximately doubled by an increase in dose from 0.5 to 1.0 g, and from 1.0 to 2.0 g. At no time did tolbutamide 0.5 g affect the plasma insulin level, neither in the fasting nor in the non-fasting state. However, this dose did reduce the blood glucose level during fasting and the increase in blood glucose in response to the meal. The latter effect was recorded within 30 min, when the serum level of tolbutamide still was close to zero. Plasma insulin concentrations did increase within 30 min after a higher dose of tolbutamide (1.0 g), when the serum concentration of tolbutamide was about 50 µmol/l. Between 2.5 and 8 h after administration of chlorpropamide 250 mg, serum drug concentrations were lower than those following tolbutamide 0.5 g. The blood glucose response was smaller and occurred later, being significant at 2 h, when the serum concentration of the drug was about 70 µmol/l. There was no significant change in plasma insulin. There was no significant pharmacokinetic difference between young and elderly subjects, except that the peak concentration of tolbutamide was higher in the latter. It appears that both for tolbutamide and chlorpropamide there is great interindividual variation in drug disposition, but food intake does not influence the bioavailability of either drug. The effect of any particular drug concentration seems dependent upon the blood glucose level and hence upon the elapsed time since the last meal. Both drugs can reduce blood glucose without an alteration in the peripheral blood concentration of insulin. This may reflect an extrapancreatic effect of the drugs, but it could also be an expression of increased insulin secretion, which is not detected because of enhanced hepatic degradation of the hormone released into the portal circulation. The observations made in young individuals are also probably relevant for elderly subjects.
Similar content being viewed by others
References
Melander, A.: Influence of food on the bioavailability of drugs. Clin. Pharmacokinet.3, 337–351 (1978)
Melander, A., Danielson, K., Hanson, A., Rudell, B., Scherstén, B., Thulin, T., Wåhlin, E.: Enhancement of hydralazine bioavailability by food. Clin. Pharmacol. Ther.22, 104–107 (1977)
Melander, A., Danielson, K., Scherstén, B., Wåhlin, E.: Enhancement of the bioavailability of propranolol and metoprolol by food. Clin, Pharmacol. Ther.22, 108–112 (1977)
Melander, A., Danielson, K., Scherstén, B., Tulin, T., Wåhlin, E.: Enhancement by food of canrenone bioavailability from spironolactone. Clin. Pharmacol. Ther.22, 100–103 (1977)
Melander, A., Wåhlin, E.: Enhancement of dicoumarol bioavailability by concomitant food intake. Eur. J. Clin. Pharmacol.14, 441–444 (1978)
Melander, A., Brante, G., Johansson, O., Lindberg, T., Wåhlin, E.: Influence of food intake on the absorption of phenytoin in man. Eur. J. Clin. Pharmacol.15, 269–274 (1979)
Levy, R. H., Pitlick, W. H., Troupin, A. S., Green, J. R., Neal, J. M.: Pharmacokinetics of carbamazepine in normal man. Clin. Pharmacol. Ther.17, 657–668 (1975)
Beermann, B., Groschinsky-Grind, M.: Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food. Eur. J. Clin. Pharmacol.13, 125–128 (1978)
Bates, T. R., Sequeira, J. A., Tembo, A. V.: Effect of food on nitrofurantoin absorption. Clin. Pharmacol. Ther.16, 63–68 (1974)
Malmborg, A.-S.: Absorption of erythromycin stearate after oral administration. Curr. Med. Res. Opin.5 (Suppl. 2), 15–18 (1978)
Melander, A., Danielson, K., Hanson, A., Jansson, K., Rerup, C., Scherstén, B., Thulin, T., Wåhlin, E.: Reduction of isoniazid bioavailability in normal men by concomitant intake of food. Acta Med. Scand.200, 93–97 (1976)
Acocella, G.: Clinical pharmacokinetics of rifampicin. Clin. Pharmacokin.3, 128–143 (1978)
Welling, P. G.: How food and fluid affect drug absorption. Postgrad. Med.62, 73–82 (1977)
Melander, A., Stenberg, P., Liedholm, H., Scherstén, B., Wåhlin-Boll, E.: Food-induced reduction of atenolol bioavailability. Eur. J. Clin. Pharmacol.17, 327–330 (1980)
Melander, A., Sartor, G., Wåhlin, E., Scherstén, B., Bitzén, P. O.: Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus. Br. Med. J. 1978/I, 142–144
Sartor, G., Scherstén, B., Melander, A.: Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. Acta Med. Scand.203, 211–214 (1978)
Wåhlin-Boll, E., Melander, A., Sartor, G., Scherstén, B.: Influence of food intake on the absorption and effect of glipizide in diabetics and healthy subjects. Eur. J. Clin. Pharmacol. (submitted)
O'Malley, K., Crooks, J., Duke, E., Stevenson, I. H.: Effect of age and sex on human drug metabolism. Br. Med. J. 1971/III, 607–609
Triggs, E. J., Nation, R. L., Long, A., Ashley, J. J.: Pharmacokinetics in the elderly. Eur. J. Clin. Pharmacol.8, 55–62 (1975)
Castleden, C. M., Kaye, C. M., Parsons, R. L.: The effect of age on plasma levels of propranolol and practolol in man. Br. J. Clin. Pharmacol.2, 303–306 (1975)
Coburn, H. J., Carrol, J. J.: Improved manual and automated colorimetric determination of serum glucose, with use of hexokinase and glucose-6-phosphate dehydrogenase. Clin. Chem.19, 127–130 (1973)
Prescott, L. F., Redman, D. R.: Gas-liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma. J. Pharm. Pharmacol.24, 713–716 (1972)
Scott, J., Poffenbarger, P. L.: Pharmacogenetics of tolbutamide metabolism in humans. Diabetes28, 41–51 (1979)
Brotherton, P. M., Grieveson, P., McMartin, C.: A study of the metabolic fate of chlorpropamide in man. Clin. Pharmacol. Ther.10, 505–514 (1969)
West, K. M., Johnson, P. C.: The comparative pharmacology of tolbutamide, carbutamide, chlorpropamide and metahexamide in man. Metabolism8, 596–605 (1959)
Feldman, J. M., Lebowitz, H. E.: Appraisal of the extrapancreatic actions of sulfonylureas. Arch. Intern. Med.123, 314–329 (1969)
Sartor, G., Melander, A., Scherstén, B., Wåhlin-Boll, E.: Serum glibenclamide in diabetic patients, and influence of food on the kinetics and dynamics of glibenclamide. Diabetologia18, 17–22 (1980)
Widström, A., Cerasi, E.: On the action of tolbutamide in normal man. II. Modulation of glucose-induced insulin release by tolbutamide. Acta Endocrinol.72, 519–531 (1973)
Grill, V., Cerasi, E.: Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat. J. Clin. Invest.61, 1346–1354 (1978)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sartor, G., Melander, A., Scherstén, B. et al. Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide. Eur J Clin Pharmacol 17, 285–293 (1980). https://doi.org/10.1007/BF00625802
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00625802